State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Molecules. 2011 Sep 5;16(9):7551-64. doi: 10.3390/molecules16097551.
Based on the analysis of the crystal structure of MG101 (1) and 20S proteasomes, a new series of peptide aldehyde derivatives were designed and synthesized. Their ability to inhibit 20S proteasome was assayed. Among them, Cbz-Glu(OtBu)-Phe-Leucinal (3c), Cbz-Glu(OtBu)-Leu-Leucinal (3d), and Boc-Ser(OBzl)-Leu-Leucinal (3o) exhibited the most activity, which represented an order of magnitude enhancement compared with MG132 (2). The covalent docking protocol was used to explore the binding mode. The structure-activity relationship of the peptide aldehyde inhibitors is discussed.
基于 MG101(1)和 20S 蛋白酶体的晶体结构分析,设计并合成了一系列新型肽醛衍生物。测定了它们抑制 20S 蛋白酶体的能力。其中,Cbz-Glu(OtBu)-Phe-Leucinal(3c)、Cbz-Glu(OtBu)-Leu-Leucinal(3d)和 Boc-Ser(OBzl)-Leu-Leucinal(3o)表现出最强的活性,与 MG132(2)相比,活性提高了一个数量级。使用共价对接方案来探索结合模式。讨论了肽醛抑制剂的构效关系。